During the last 50 years, there was a gentle enchancment within the therapy final result of acute myeloid leukemia (AML). Nonetheless, median survival within the aged continues to be poor because of intolerance to intensive chemotherapy and better numbers of sufferers with hostile cytogenetics. Fadraciclib (CYC065), a novel cyclin-dependent kinase (CDK) 2/9 inhibitor, has preclinical efficacy in AML.
In AML cell strains, myeloid cell leukemia 1 (MCL-1) was downregulated following therapy with fadraciclib, leading to a fast induction of apoptosis. As well as, RNA polymerase II (RNAPII)-driven transcription was suppressed, rendering a world gene suppression. Fast induction of apoptosis was noticed in major AML cells after therapy with fadraciclib for 6-Eight h. Twenty-four hours steady therapy additional elevated efficacy of fadraciclib.
Though preliminary outcomes confirmed that AML cell strains harboring KMT2A rearrangement (KMT2A-r) are extra delicate to fadraciclib, we discovered that the drug can induce apoptosis and reduce MCL-1 expression in major AML cells, no matter KMT2A standing. Importantly, the range of genetic mutations noticed in major AML affected person samples was related to variable response to fadraciclib, confirming the necessity for affected person stratification to allow a simpler and customized therapy strategy.
Synergistic exercise was demonstrated when fadraciclib was mixed with the BCL-2 inhibitor venetoclax, or the traditional chemotherapy brokers, cytarabine, or azacitidine, with the mix of fadraciclib and azacitidine having essentially the most favorable therapeutic window. In abstract, these outcomes spotlight the potential of fadraciclib as a novel therapeutic strategy for AML.
Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C
Chemotherapy resistance stays to be the first barrier to acute myeloid leukemia (AML) therapy failure. Nuclear factor-erythroid 2-related issue 2 (Nrf2) has been effectively established as a really pleiotropic transcription issue. Inhibition of Nrf2 perform will increase the sensitivity of varied chemotherapeutics and overcomes chemoresistance successfully.
Brusatol (Bru) has been reported to lower Nrf2 protein expression particularly by ubiquitin degradation of Nrf2. Nonetheless, it stays elusive whether or not mixture of Brusatol and Cytarabine (Ara-C) elicits a synergistic antitumor impact in AML. Our outcomes demonstrated that mixture of Ara-C and Brusatol synergistically exerted exceptional pro-apoptosis impact in HL-60 and THP-1 cells. Mechanistically, synergistic anti-tumor impact of Ara-C/Brusatol in AML cells is mediated by attenuating Nrf2 expression.
To our shock, Nrf2 inhibition by Brusatol causes downregulation of the expression of glycolysis-related proteins and decreased glucose consumption and lactate manufacturing, whereas the extent of ROS manufacturing was unaffected. The activation of Nrf2 by Sulforaphane (SFP) may reverse the chemotherapeutic impact and adjustments of glycolysis of concomitant of Ara-C with Brusatol in AML cell strains.
Moreover, Ara-C/Brusatol co-treatment decreased Glucose-6-phosphate dehydrogenase (G6PD) protein expression and elevated the sensitivity of Ara-C. Furthermore, the mouse xenograft in vivo experiment confirmed that combining Ara-C with Brusatol exerted stronger antileukemia than Ara-C alone. The efficacy, along with the mechanistic observations, reveals the potential of concurrently giving these two medication and offers a rational foundation for focusing on glucose catabolism in future scientific therapeutic strategy.
Utility of a Easy Microfluidic Chip Evaluation Expertise to Consider the Inhibitory Function of Protocatechuic Acid on Shear-Induced Platelet Aggregation
This research aimed to develop a easy microfluidic chip evaluation know-how to review the inhibitory impact of protocatechuic acid on shear-induced platelet aggregation. The microfluidic chip designed on this research simulates 80% fastened slim microchannels. This microchannel slim mannequin makes use of the finite factor evaluation module of the three-dimensional modeling software program solidwork to research fluid dynamic habits. Blood handled with protocatechuic acid at 1, 2, 4, 8, or 16 µg/mL was handed via the microchannel stenosis mannequin at a shear fee of 10,000 s-1. The platelet adhesion and aggregation behaviors have been then measured utilizing fluorescence microscopy and noticed in actual time.
Concurrently, the antiplatelet aggregation impact of protocatechuic acid was analyzed utilizing thromboelastography and photoelectric turbidimetry. The designed stenosis mannequin of the microfluidic chip can produce a gradient of fluid shear fee, and the gradient of fluid shear fee can induce platelet aggregation. Underneath this mannequin, the diploma of platelet adhesion and aggregation elevated because the shear fee elevated.
Within the experimental focus vary of 0-8 µmol/mL, protocatechuic acid exerted a concentration-dependent inhibition of platelet aggregation. In distinction, thromboelastography and photoelectric turbidimetry didn’t exhibit an inhibitory impact. The microfluidic chip evaluation know-how developed on this research can be utilized to review the impact of protocatechin in inhibiting platelet aggregation induced by shear fee in vitro. This know-how is straightforward to function and can be utilized as a brand new sort of antiplatelet aggregation evaluation know-how for screening research of novel potential antiplatelet aggregation medication.
A neuroimaging dataset on response inhibition and selective consideration in adults and kids with and with out ADHD
On this article we describe the dataset titled “Response inhibition and selective consideration in adults and kids with and with out ADHD” which is publicly obtainable on OpenNeuro.org. This dataset is comprised of neuroimaging and standardized cognitive evaluation scores from 11 adults, 12 youngsters recognized with Consideration Deficit Hyperactivity Dysfunction (ADHD) and 15 age matched youngsters with out ADHD.
Ribonuclease Inhibitor (RI) Antibody |
|||
| abx102050-200l | Abbexa | 200 µl | EUR 337.5 |
Ribonuclease Inhibitor (RI) Antibody |
|||
| abx102051-100l | Abbexa | 100 µl | EUR 275 |
Ribonuclease Inhibitor (RI) Antibody |
|||
| abx102051-1ml | Abbexa | 1 ml | EUR 775 |
Ribonuclease Inhibitor (RI) Antibody |
|||
| abx102051-200l | Abbexa | 200 µl | EUR 350 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody |
|||
| CAU25928-100ul | Biomatik Corporation | 100ul | EUR 241.9 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody |
|||
| CAU25928-200ul | Biomatik Corporation | 200ul | EUR 302.4 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody |
|||
| CAU25929-100ul | Biomatik Corporation | 100ul | EUR 229.4 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody |
|||
| CAU25929-200ul | Biomatik Corporation | 200ul | EUR 287.3 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody |
|||
| CAU25930-100ul | Biomatik Corporation | 100ul | EUR 222.7 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody |
|||
| CAU25930-200ul | Biomatik Corporation | 200ul | EUR 278.9 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| PAB444Hu01 | Cloud-Clone | 100ul | EUR 232 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| PAB444Mu01 | Cloud-Clone | 100ul | EUR 239 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| PAB444Ra01 | Cloud-Clone | 100ul | EUR 252 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2015243-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2015243-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2015243-05mL | MyBiosource | 0.5mL | EUR 365 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2015243-1mL | MyBiosource | 1mL | EUR 445 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2015243-5mL | MyBiosource | 5mL | EUR 1220 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2016710-01mL | MyBiosource | 0.1mL | EUR 170 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2016710-02mL | MyBiosource | 0.2mL | EUR 215 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2016710-05mL | MyBiosource | 0.5mL | EUR 350 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2016710-1mL | MyBiosource | 1mL | EUR 425 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2016710-5mL | MyBiosource | 5mL | EUR 1160 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2017196-01mL | MyBiosource | 0.1mL | EUR 170 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2017196-02mL | MyBiosource | 0.2mL | EUR 205 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2017196-05mL | MyBiosource | 0.5mL | EUR 335 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2017196-1mL | MyBiosource | 1mL | EUR 415 |
Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2017196-5mL | MyBiosource | 5mL | EUR 1130 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse) |
|||
| 4-PAB444Mu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI) |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), PE |
|||
| 4-PAB444Mu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with PE. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), APC |
|||
| 4-PAB444Mu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with APC. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), Cy3 |
|||
| 4-PAB444Mu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with Cy3. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), HRP |
|||
| 4-PAB444Mu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with HRP. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Rat) |
|||
| 4-PAB444Ra01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Ribonuclease Inhibitor (RI) |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), FITC |
|||
| 4-PAB444Mu01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with FITC. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Mouse) |
|||
| 4-PAB444Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Ribonuclease Inhibitor (RI) |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Rat), PE |
|||
| 4-PAB444Ra01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Ribonuclease Inhibitor (RI). This antibody is labeled with PE. |
|||
Rat Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100392-10x96Tests | MyBiosource | 10x96Tests | EUR 1595 |
Rat Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100392-10x96TestsMBS2090685AbPairsSupportPack110x96Tests | MyBiosource | 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests) | EUR 1715 |
Rat Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100392-5x96Tests | MyBiosource | 5x96Tests | EUR 1005 |
Rat Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100392-5x96TestsMBS2090685AbPairsSupportPack15x96Tests | MyBiosource | 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests) | EUR 1080 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Rat), APC |
|||
| 4-PAB444Ra01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Ribonuclease Inhibitor (RI). This antibody is labeled with APC. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Rat), Cy3 |
|||
| 4-PAB444Ra01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Ribonuclease Inhibitor (RI). This antibody is labeled with Cy3. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Rat), HRP |
|||
| 4-PAB444Ra01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Ribonuclease Inhibitor (RI). This antibody is labeled with HRP. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Mouse), PE |
|||
| 4-PAB444Hu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with PE. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Rat), FITC |
|||
| 4-PAB444Ra01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Ribonuclease Inhibitor (RI). This antibody is labeled with FITC. |
|||
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055224-01mL | MyBiosource | 0.1mL | EUR 260 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055224-02mL | MyBiosource | 0.2mL | EUR 335 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055224-05mL | MyBiosource | 0.5mL | EUR 630 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055224-1mL | MyBiosource | 1mL | EUR 770 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055224-5mL | MyBiosource | 5mL | EUR 2210 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055230-01mL | MyBiosource | 0.1mL | EUR 265 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055230-02mL | MyBiosource | 0.2mL | EUR 350 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055230-05mL | MyBiosource | 0.5mL | EUR 645 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055230-1mL | MyBiosource | 1mL | EUR 795 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055230-5mL | MyBiosource | 5mL | EUR 2275 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055236-01mL | MyBiosource | 0.1mL | EUR 275 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055236-02mL | MyBiosource | 0.2mL | EUR 365 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055236-05mL | MyBiosource | 0.5mL | EUR 675 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055236-1mL | MyBiosource | 1mL | EUR 835 |
PE-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055236-5mL | MyBiosource | 5mL | EUR 2395 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), Biotinylated |
|||
| 4-PAB444Mu01-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with Biotin. |
|||
Human Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100390-10x96Tests | MyBiosource | 10x96Tests | EUR 1480 |
Human Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100390-10x96TestsMBS2090685AbPairsSupportPack110x96Tests | MyBiosource | 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests) | EUR 1600 |
Human Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100390-5x96Tests | MyBiosource | 5x96Tests | EUR 935 |
Human Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100390-5x96TestsMBS2090685AbPairsSupportPack15x96Tests | MyBiosource | 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests) | EUR 1010 |
Mouse Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100391-10x96Tests | MyBiosource | 10x96Tests | EUR 1515 |
Mouse Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100391-10x96TestsMBS2090685AbPairsSupportPack110x96Tests | MyBiosource | 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests) | EUR 1640 |
Mouse Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100391-5x96Tests | MyBiosource | 5x96Tests | EUR 960 |
Mouse Ribonuclease Inhibitor (RI) Antibody Pair Kit (with Standard) |
|||
| MBS2100391-5x96TestsMBS2090685AbPairsSupportPack15x96Tests | MyBiosource | 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests) | EUR 1035 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPB444Hu01 | Cloud-Clone | 10ug | EUR 178 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| 4-RPB444Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Ribonuclease Inhibitor expressed in: E.coli |
|||
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPB444Hu02 | Cloud-Clone | 10ug | EUR 182 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPB444Hu03 | Cloud-Clone | 10ug | EUR 182 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPB444Mu01 | Cloud-Clone | 10ug | EUR 180 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| 4-RPB444Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Ribonuclease Inhibitor expressed in: E.coli |
|||
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPB444Ra01 | Cloud-Clone | 10ug | EUR 194 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| 4-RPB444Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Ribonuclease Inhibitor expressed in: E.coli |
|||
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43651-100ug | Biomatik Corporation | 100ug | EUR 550 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43651-1mg | Biomatik Corporation | 1mg | EUR 2434.9 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43651-50ug | Biomatik Corporation | 50ug | EUR 441.1 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43652-100ug | Biomatik Corporation | 100ug | EUR 599.5 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43652-1mg | Biomatik Corporation | 1mg | EUR 2653.3 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43652-50ug | Biomatik Corporation | 50ug | EUR 480.7 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43653-100ug | Biomatik Corporation | 100ug | EUR 554.4 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43653-1mg | Biomatik Corporation | 1mg | EUR 2457 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU43653-50ug | Biomatik Corporation | 50ug | EUR 445.5 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU59540-100ug | Biomatik Corporation | 100ug | EUR 613.2 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU59540-1mg | Biomatik Corporation | 1mg | EUR 2667.6 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU59540-50ug | Biomatik Corporation | 50ug | EUR 545.6 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU59541-100ug | Biomatik Corporation | 100ug | EUR 613.2 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU59541-1mg | Biomatik Corporation | 1mg | EUR 2667.6 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| RPU59541-50ug | Biomatik Corporation | 50ug | EUR 545.6 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018628-001mg | MyBiosource | 0.01mg | EUR 175 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018628-005mg | MyBiosource | 0.05mg | EUR 310 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018628-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018628-02mg | MyBiosource | 0.2mg | EUR 575 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018628-05mg | MyBiosource | 0.5mg | EUR 1090 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018646-001mg | MyBiosource | 0.01mg | EUR 170 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018646-005mg | MyBiosource | 0.05mg | EUR 305 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018646-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018646-02mg | MyBiosource | 0.2mg | EUR 570 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018646-05mg | MyBiosource | 0.5mg | EUR 1080 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018747-001mg | MyBiosource | 0.01mg | EUR 180 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018747-005mg | MyBiosource | 0.05mg | EUR 330 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018747-01mg | MyBiosource | 0.1mg | EUR 500 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018747-02mg | MyBiosource | 0.2mg | EUR 615 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2018747-05mg | MyBiosource | 0.5mg | EUR 1170 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125485-001mg | MyBiosource | 0.01mg | EUR 175 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125485-005mg | MyBiosource | 0.05mg | EUR 315 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125485-01mg | MyBiosource | 0.1mg | EUR 475 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125485-02mg | MyBiosource | 0.2mg | EUR 580 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125485-05mg | MyBiosource | 0.5mg | EUR 1100 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125486-001mg | MyBiosource | 0.01mg | EUR 175 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125486-005mg | MyBiosource | 0.05mg | EUR 315 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125486-01mg | MyBiosource | 0.1mg | EUR 475 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125486-02mg | MyBiosource | 0.2mg | EUR 580 |
Recombinant Ribonuclease Inhibitor (RI) |
|||
| MBS2125486-05mg | MyBiosource | 0.5mg | EUR 1100 |
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Mouse), APC |
|||
| 4-PAB444Hu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with APC. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Mouse), Cy3 |
|||
| 4-PAB444Hu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with Cy3. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Human, Mouse), HRP |
|||
| 4-PAB444Hu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with HRP. |
|||
Ribonuclease Inhibitor (RI) Polyclonal Antibody (Mouse), APC-Cy7 |
|||
| 4-PAB444Mu01-APC-Cy7 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Ribonuclease Inhibitor (RI). This antibody is labeled with APC-Cy7. |
|||
APC-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055225-01mL | MyBiosource | 0.1mL | EUR 260 |
APC-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055225-02mL | MyBiosource | 0.2mL | EUR 335 |
APC-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055225-05mL | MyBiosource | 0.5mL | EUR 630 |
APC-Linked Polyclonal Antibody to Ribonuclease Inhibitor (RI) |
|||
| MBS2055225-1mL | MyBiosource | 1mL | EUR 770 |
Useful Magnetic Resonance Imaging (fMRI) information have been collected whereas contributors accomplished selective consideration and response inhibition duties designed and balanced for inside or cross-task comparisons. Earlier analysis using this dataset has but to discover associations between mind perform and cognitive evaluation scores or variations in neural processes throughout stimuli options making this dataset helpful for its future contributions to the sector in addition to replication of prior findings.